Variant Summary
- HGVS
- —
- Variant Type(s)
- coding_transcript_variant
- Evidence Items
- 3
Evidence Level Distribution
Level B: 2Level D: 1
Evidence Items
Showing CIViC evidence rows where gene = HRAS and variant = Mutation.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| D | Predictive | Supports | Sensitivity/Response | Cancer | Everolimus,Binimetinib,Mirdametinib,Selumetinib,MTOR Kinase Inhibitor AZD8055 | 3 |
| B | Predictive | Supports | Sensitivity/Response | Bladder Urothelial Carcinoma | Tipifarnib | 2 |
| B | Predictive | Supports | Sensitivity/Response | Head And Neck Squamous Cell Carcinoma | Tipifarnib | 2 |